Is Bluejay Diagnostics, Inc. Worth Investing In | Penny Stock Analysis
Manage episode 370981751 series 3475815
Full Playlist: https://youtube.com/playlist?list=PLGvBbL_es1xo3Oly9nksjk0qrdwA2Fia9
Becoming Ritchie Rich is a new show that takes a deep dive into various penny stocks. If you are someone who wants to learn about the stock market or trades penny stocks, this show is for you. Join me as we do some deep analysis of a popular penny stock. Feel free to ask questions, give suggestions, and share penny stocks you'd like me to take a look at next. Today's popular penny stock is Bluejay Diagnostics (BJDX).
The Investing Bloog Room:
https://www.bloogspace.com/investingbloogroom.html
Weerdy:
https://Weerdy.com
BJDX Stock:
Bluejay Diagnostics, Inc. operates as a diagnostic company. It develops and markets minimally-invasive Point-of-Care diagnostics tests and devices that provide patients and providers with access to affordable and timely healthcare.
More About BJDX:
Bluejay Diagnostics, Inc. is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a near-patient testing system for triage and monitoring of disease progression. The Company's Symphony platform is a technology platform that provides measurements of key diagnostic biomarkers found in whole blood. The Symphony analyzer orchestrates whole blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force. The Company's first product candidate, an IL-6 test for sepsis triage, is designed to provide results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and better triage/treatment decisions. The Symphony platform and its initial biomarker test, Symphony IL-6 test, is suited to address a subset of the global in vitro diagnostics devices (IVDs) market, including sepsis, cardio-metabolic diseases, cancer, and other diseases that require rapid tests.
BJDX Financial Summary:
Bluejay Diagnostics, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was USD 2.54 million compared to USD 2.01 million a year ago. Basic loss per share from continuing operations was USD 0.12 compared to USD 0.1 a year ago.
About the Host:
Ritchie "Rick Da Don" Knox is a serial entrepreneur, investor, media personality, musician, artist, and philanthropist from Detroit, Michigan (USA).
Disclaimer:
Becoming Ritchie Rich's host Ritchie Rich is not a financial advisor. This show is created purely for entertainment purposes. Before buying into any position, please DO YOUR OWN RESEARCH.
#Investing #investinginmyfuture #investinginmyself #InvestingInRealEstate #investinginme #investingbooks #investingquotes #investingeducation #investingforus #investinginyourself #InvestInGold #investingstrategy #investinginyourhealth #investinginthefuture #investingwordsofwisdom #investinginyourpeople #investingtips #investingwithjg #investingplanning #Investingnetworkclub #INVESTINGINHISTORY #investingabroad #investinghana #investinginhumanpotential #investingday #InvestingForU #investingourself #investingforwealth #investingolnetworkmarketing #investingnoob
Thanks for LIKING, SHARING, and COMMENTING on this video!
132 jaksoa